Optical fluorescent imaging to monitor temporal effects of microbubble-mediated ultrasound therapy

IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control

Volumn 60, Issue 2, 2013, Pages 281-289

  Sorace, Anna G ^a   Saini, Reshu ^a   Rosenthal, Eben ^b   Warram, Jason M ^c   Zinn, Kurt R ^c,d   Hoyt, Kenneth ^a,c,d  

^a and Radiation Oncology   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER CELLS; CANCER MODELS; CANCER THERAPY; DYE CONCENTRATION; EX-VIVO; FLUORESCENT IMAGING; FLUORESCENT MOLECULES; IN-VIVO; MICROBUBBLE CONTRAST AGENTS; NONINVASIVE OPTICAL IMAGING; OPTICAL IMAGING SYSTEM; SMALL ANIMAL; SMALL MOLECULES; TEMPORAL EFFECTS; TEMPORAL INFORMATION; THERAPEUTIC EFFECTS; ULTRASOUND THERAPY;

ACOUSTIC FIELDS; ANIMALS; DRUG DELIVERY; EMULSIFICATION; MOLECULES; OPTICAL IMAGE STORAGE; TUMORS;

FLUORESCENCE;

CARBOCYANINE; CONTRAST MEDIUM; CY5.5 CYANINE DYE; FLUORESCENT DYE; IMMUNOGLOBULIN G;

ANIMAL; ARTICLE; CHEMISTRY; EXPERIMENTAL NEOPLASM; FEMALE; FLUORESCENCE IMAGING; HUMAN; METABOLISM; METHODOLOGY; MICROBUBBLE; MOUSE; NUDE MOUSE; TUMOR CELL LINE; ULTRASOUND THERAPY;

ANIMALS; CARBOCYANINES; CELL LINE, TUMOR; CONTRAST MEDIA; FEMALE; FLUORESCENT DYES; HUMANS; IMMUNOGLOBULIN G; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; MICROBUBBLES; OPTICAL IMAGING; ULTRASONIC THERAPY;

MLCS; MLOWN;

EID: 84873818084     PISSN: 08853010     EISSN: None     Source Type: Journal    
DOI: 10.1109/TUFFC.2013.2564     Document Type: Article

References (43)

1. American cancer society "Cancer facts and fgures 2011," am. Cancer soc., atlanta, Ga, 2011.
2. G. Orive, R. M. Hernandex, A. Rodriguez Gascon, A. Dominguex-Gil, and J. L. Pedraz, "Drug delivery in biotechnology: Present and future," Curr. Opin. Biotechnol., vol. 14, no. 6, pp. 659-664, 2003. (Pubitemid 37518447)
3. P. Carter, "Improving the efcacy of antibody-based cancer therapies," Nat. Rev. Cancer, vol. 1, no. 2, pp. 118-129, 2001. (Pubitemid 33741887)
4. A. Casadevall, E. Dadachova, and L. Pirofski, "Passive antibody therapy for infectious diseases," Nat. Rev. Microbiol., vol. 2, no. 9, pp. 695-703, 2004. (Pubitemid 39200062)
5. H. Maeda, K. Tominaga, K. Iwanaga, F. Nagao, M. Habu, T. Tsuji-sawa, Y. Seta, K. Toyoshima, J. Fukuda, and T. Nishihara, "Targeted drug delivery system for oral cancer therapy using sonoporation," J. Oral Pathol. Med., vol. 38, no. 7, pp. 572-579, 2009.
6. M. Rudin and R. Weissleder, "Molecular imaging in drug discovery and development," Nat. Rev. Drug Discov., vol. 2, no. 2, pp. 123-131, 2003. (Pubitemid 37361644)
7. K. Licha and C. Olbrich, "Optical imaging in drug discovery and diagnostic applications," Adv. Drug Deliv. Rev., vol. 57, no. 8, pp. 1087-1108, 2005. (Pubitemid 40797571)
8. N. De Jong, P. J. Frinking, I. Bouakaz, and F. J. Ten cate, "Detection of procedures of ultrasound contrast agents," Ultrasonics, vol. 38, no. 1-8, pp. 87-92, 2000. (Pubitemid 30592603)
9. R. Gramiak and P. M. Shah, "Echocardiography of the aortic root," Invest. Radiol., vol. 3, no. 5, pp. 356-366, 1968.
10. K. Ferrara, R. Pollard, and M. Borden, "Ultrasound microbubble contrast agents: Fundamentals and application to gene and drug delivery," Annu. Rev. Biomed. Eng., vol. 9, pp. 415-447, 2007. (Pubitemid 350246663)
11. W. F. Armstrong, T. M. Mueller, E. L. Kinney, E. G. Tickner, J. C. Dillon, and H. Feigenbaum, "Assessment of myocardial perfusion abnormalities with contrast-enhanced two-dimensional echocardiog-raphy," Circulation, vol. 66, no. 1, pp. 166-173, 1982. (Pubitemid 12069971)
12. D. Dalecki, "Mechanical bioefects of ultrasound," Annu. Rev. Biomed. Eng., vol. 6, pp. 229-248, 2004.
13. M. Kinoshita, N. Mcdannold, F. A. Jolesz, and K. Hynynen, "Targeted delivery of antibodies through the blood-brain barrier by MrI-guided focused ultrasound," Biochem. Biophys. Res. Commun., vol. 340, no. 4, pp. 1085-1090, 2006. (Pubitemid 43083389)
14. A. Van Wamel, A. Bouakaz, and N. De Jong, "Duration of ultrasound bubbles enhanced membrane permeability," in Proc. 2003 IEEE Ultrasonics Symp., pp. 917-920.
15. A. Van Wamel, K. Kooiman, M. Harteveld, M. Emmer, F. J. Ten cate, M. Versluis, and N. De Jong, "Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation," J. Control. Release, vol. 112, no. 2, pp. 149-155, 2006.
16. S. B. Raymond, L. H. Treat, J. D. Dewey, N. J. Mcdannold, K. Hynynen, and B. J. Bacskai, "Ultrasound enhanced delivery of molecular imaging and therapeutic agents in alzheimer's disease mouse models," PLoS ONE, vol. 3, no. 5, art. No. E2175, 2008.
17. R. Bekeredjian, R. D. Kroll, E. Fein, S. Tinkov, C. Coester, G. Winter, H. A. Katus, and H. Kulaksiz, "Ultrasound targeted micro-bubble destruction increases capillary permeability in hepatomas," Ultrasound Med. Biol., vol. 33, no. 10, pp. 1592-1598, oct. 2007. (Pubitemid 47444492)
18. A. G. Sorace, J. M. Warram, H. Umphrey, and K. Hoyt, "Mi-croubble- mediated ultrasonic techniques for improved drug delivery in cancer," J. Drug Target., vol. 20, no. 1, pp. 43-54, 2012.
19. J. M. Escofre, J. Piron, A. Novell, and A. Bouakaz, "Doxorubicin delivery into tumor cells with ultrasound and microbubbles," Mol. Pharm., vol. 8, no. 3, pp. 799-806, 2011.
20. C. Uhlemann, B. Heinig, and U. Wollina, "Therapeutic ultrasound lower extremity wound management," Int. J. Low. Extrem. Wounds, vol. 2, no. 3, pp. 152-157, 2003.
21. K. Breuing, L. Bayer, J. Neuwalder, and D. P. Orgill, "Early experience using low-frequency ultrasound in chronic wounds," Ann. Plast. Surg., vol. 55, no. 2, pp. 183-187, 2005. (Pubitemid 41045281)
22. D. L. Miller, S. V. Pislaru, and J. E. Greenleaf, "Sonoporation: Mechanical dna delivery by ultrasonic cavitation," Somat. Cell Mol. Genet., vol. 27, no. 1-6, pp. 115-134, 2002. (Pubitemid 36553831)
23. J. Wu, J. Pepe, and M. Rincon, "Sonoporation, anti-cancer drug and antibody delivery using ultrasound," Ultrasonics, vol. 44, suppl. 1, pp. E21-35, 2006.
24. H. Hosseinkhani, T. Aoyama, O. Ogawa, and Y. Tabata, "Ultrasound enhanced the transfection of plasmid dna by non-viral vectors," Curr. Pharm. Biotechnol., vol. 4, no. 2, pp. 109-122, 2003. (Pubitemid 36416868)
25. D. Mukherjee, J. Wong, B. Grifn, S. G. Ellis, T. Porter, S. Sen, and J. D. Thomas, "Ten-fold augmentation of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration," J. Am. Coll. Cardiol., vol. 35, no. 6, pp. 1678-1686, 2000. (Pubitemid 30307516)
26. C. H. Heath, A. Sorace, J. Knowles, E. Rosenthal, and K. Hoyt, "Microbubble therapy enhanced anti-tumor properties of cisplatin and cetuximab in vitro and in vivo," Otolaryngol. Head Neck Surg., vol. 146, no. 6, pp. 938-945, 2012.
27. W. D. Figg and H. L. Mcleod, "Engineered antibodies and immu-notoxins," in Handbook of AntiCancer Pharmacokinetics and Phar-macodynamics, Totown, nJ: Humana Press, 2004.
28. A. Abulrob, E. Brunette, J. Slinn, E. Baumann, and D. Stani-mirovic, "In vivo optical imaging of ischemic blood-brain barrier disruption," in Permeability Barrier, Totown, nJ: Humana Press, 2011.
29. J. Stadlmann, M. Pabst, D. Kolarich, R. Kunert, and F. Altmann, "Analysis of immunoglobulin glycosylation by lc-EsI-Ms of gly-copeptides and oligosaccharides," Proteomics, vol. 8, no. 14, pp. 2858-2871, 2008.
30. Eribitux Insert, Eribitux Drug Description, bristol-Myers squibb co., Princeton, nJ, 2011.
31. L. G. Presta, H. Chen, S. J. O'connor, V. Chisholm, Y. G. Meng, L. Krummen, M. Winkler, and N. Ferrara, "Humanization of an anti-vascular endothelial growthfactor monoclonal antibody for the therapy of solid tumors and other disorders," Cancer Res., vol. 57, no. 20, pp. 4593-4599, 1997. (Pubitemid 27441066)
32. G. E. Healthcare, "Amersham Fluorolink cy5.5 Monofunctional dye 5-pack," G. E. Healthcare, Waukesha, WI, Product specifca-tion sheet, 2011.
33. Abraxane Insert, Abraxane Drug Description, abraxis bioscience Inc., celgene corp., summit, nJ, 2011.
34. D. J. Buchsbaum, T. Zhou, W. E. Grizzle, P. G. Oliver, C. J. Hammond, S. Zhang, M. Carpenter, and A. F. Lobulio, "Antitumor ef-fcacy of Tra-8 anti-dr5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model," Clin. Cancer Res., vol. 9, no. 10, pt. 1, pp. 3731-3741, 2003. (Pubitemid 37169242)
35. Y.-H. Zhao, C.-T. Lu, Z.-C. Zhou, Z. Jin, L. Zhang, C. Z. Sun, Y. Y. Xu, H. S. Gao, J. L. Tian, F. H. Gao, Q. Q. Tang, W. Li, Q. Xiang, X. K. Li, and W. F. Li, "Enhancing chemotherapeutic drug inhibition on tumor growth by ultrasound: an in vivo experiment," J. Drug Target., vol. 19, no. 2, pp. 154-160, 2011.
36. A. P. Gibson, J. C. Hebden, and S. R. Arridge, "Recent advances in difuse optical imaging," Phys. Med. Biol., vol. 50, no. 4, pp. R1-r43, 2005. (Pubitemid 40309196)
37. J. C. Hebden, S. R. Arridge, and D. T. Delpy, "Optical imaging in medicine. I. Experimental techniques," Phys. Med. Biol., vol. 42, no. 5, pp. 825-840, 1997. (Pubitemid 27263503)
38. S. R. Arridge and J. C. Hebden, "Optical imaging in medicine II. Modeling and reconstruction," Phys. Med. Biol., vol. 42, no. 5, pp. 841-853, 1997. (Pubitemid 27263504)
39. B. I. Lee and J.-J. Min, "Molecular imaging using bioluminescence," Open Nucl. Med. J., vol. 2, pp. 157-165, 2010.
40. D. J. Hawrysz and E. M. Sevick-Muraca, "Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fuorescent contrast agents," Neoplasia, vol. 2, no. 5, pp. 388-417, 2000. (Pubitemid 32044786)
41. J. V. Frangioni, "In vivo near-infrared fuorescence imaging," Curr. Opin. Chem. Biol., vol. 7, no. 5, pp. 626-634, 2003.
42. U. Mahmood, C.-H. Tung, A. Bogdanov, and R. Weissleder, "Near-infrared optical imaging of protease activity for tumor detection," Radiology, vol. 213, no. 3, pp. 866-870, 1999.
43. A. Petrovsky, E. Schellenberger, L. Josephson, R. Weissleder, and A. Bogdanov, "Near-infrared fuorescent imaging of tumor apopto-sis," Cancer Res., vol. 63, no. 8, pp. 1936-1942, 2003. (Pubitemid 36460861)